DNA (Ginkgo Bioworks Holdings) 3-Year Dividend Growth Rate: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DNA Ginkgo Bioworks Holdings Inc DNA
62 GF Score
Price $6.88
GF Value $5.87
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Ginkgo Bioworks Holdings 3-Year Dividend Growth Rate?

Ginkgo Bioworks Holdings DNA +1.93% 62 3-Year Dividend Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates DNA with a GF Score™ of 62/100 and a GF Value™ of $5.87 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 95 Biotechnology companies, Ginkgo Bioworks Holdings ranks worse than 1052630.53% on this metric.

Ginkgo Bioworks Holdings's Dividends per Share for the three months ended in Jun. 2026 was $0.00.

The historical rank and industry rank for Ginkgo Bioworks Holdings's 3-Year Dividend Growth Rate or its related term are showing as below:

DNA's 3-Year Dividend Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 5.2
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Ginkgo Bioworks Holdings's Dividend Payout Ratio for the three months ended in Jun. 2026 was 0.00. As of today, Ginkgo Bioworks Holdings's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Ginkgo Bioworks Holdings  (NYSE:DNA) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Ginkgo Bioworks Holdings's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=0/ -0.939
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ginkgo Bioworks Holdings 3-Year Dividend Growth Rate Related Terms>


DNA vs PBYI, CCCC, RLMD: 3-Year Dividend Growth Rate Comparison

For the Biotechnology subindustry, Ginkgo Bioworks Holdings's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ginkgo Bioworks Holdings 3-Year Dividend Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ginkgo Bioworks Holdings's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Ginkgo Bioworks Holdings's 3-Year Dividend Growth Rate falls into.


DNA
62GF Score
Ginkgo Bioworks Holdings Inc DNA
3-Year Dividend Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ginkgo Bioworks Holdings 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 3-Year Dividend Growth Rate of 0.00% mean?
Ginkgo Bioworks Holdings (DNA) has a 3-Year Dividend Growth Rate of 0.00% as of Jun. 2026. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Ginkgo Bioworks Holdings and its competitors. According to the industry distribution chart, Ginkgo Bioworks Holdings ranks #999999 out of 95 companies in the Biotechnology industry.
Is Ginkgo Bioworks Holdings' 3-Year Dividend Growth Rate too high?
Ginkgo Bioworks Holdings' current 3-Year Dividend Growth Rate is 0.00%. Based on the distribution chart, Ginkgo Bioworks Holdings ranks #999999 out of 95 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Ginkgo Bioworks Holdings has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ginkgo Bioworks Holdings' 3-Year Dividend Growth Rate compare to PBYI and CCCC?
According to the Biotechnology industry distribution chart, Ginkgo Bioworks Holdings ranks #999999 out of 95 companies for 3-Year Dividend Growth Rate. This places Ginkgo Bioworks Holdings in the lower half of its industry. The industry median 3-Year Dividend Growth Rate is 5.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Biotechnology company?
The median 3-Year Dividend Growth Rate among Biotechnology companies is 5.20, based on 95 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Ginkgo Bioworks Holdings and its competitors. For the Biotechnology industry, the median 3-Year Dividend Growth Rate is 5.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ginkgo Bioworks Holdings's current 3-Year Dividend Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginkgo Bioworks Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ginkgo Bioworks Holdings (DNA) is currently considered Modestly Overvalued. The stock's GF Value™ is $5.87, compared to a current price of $6.88 — trading 17.2% above its estimated fair value. The current 3-Year Dividend Growth Rate is 0.00%. Ginkgo Bioworks Holdings' overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For Ginkgo Bioworks Holdings (DNA), the current 3-Year Dividend Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ginkgo Bioworks Holdings (DNA) Overvalued in 2026?

Based on GuruFocus' analysis, Ginkgo Bioworks Holdings stock appears to be overvalued. The current stock price of $6.88 is trading 17.2% above its estimated GF Value™ of $5.87. GuruFocus considers Ginkgo Bioworks Holdings to be Modestly Overvalued.

Key valuation signals for DNA:

  • 3-Year Dividend Growth Rate: 0.00%
  • GF Value™: $5.87 vs. price of $6.88 (17.2% above fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the DNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ginkgo Bioworks Holdings Business Description

Other Exchanges DNA:Mexico
Address 27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
62GF Score

Get the complete analysis for DNA

3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.88
Price
$5.87
GF Value